title: Chapter 8 Military Personnel With Traumatic Brain Injuries and Insomnia Have Reductions in PTSD and Improved Perceived Health Following Sleep Restoration: A Relationship Moderated by Inflammation.
abstract: BACKGROUND
  Up to one-third of deployed military personnel sustain a traumatic brain injury (TBI). TBIs and the stress of deployment contribute to the vulnerability for chronic sleep disturbance, resulting in high rates of insomnia diagnoses as well as symptoms of posttraumatic stress disorder (PTSD), depression, and declines in health-related quality of life (HRQOL). Inflammation is associated with insomnia; however, the impact of sleep changes on comorbid symptoms and inflammation in this population is unknown.
  
  
  METHODS
  In this study, we examined the relationship between reported sleep changes and the provision of the standard of care, which could include one or more of the following: cognitive behavioral therapy (CBT), medications, and continuous positive airway pressure (CPAP). We compared the following: (a) the group with a decrease in the Pittsburgh Sleep Quality Index (PSQI; restorative sleep) and (b) the group with no change or increase in PSQI (no change). Independent t tests and chi-square tests were used to compare the groups on demographic and clinical characteristics, and mixed between-within subjects analysis of variance tests were used to determine the effect of group differences on changes in comorbid symptoms. Linear regression models were used to examine the role of inflammation in changes in symptoms and HRQOL.
  
  
  RESULTS
  The sample included 70 recently deployed military personnel with TBI, seeking care for sleep disturbances. Thirty-seven participants reported restorative sleep and 33 reported no sleep changes or worse sleep. The two groups did not differ in demographic characteristics or clinical symptoms at baseline. The TBI+restored sleep group had significant reductions in PTSD and depression over the 3-month period, whereas the TBI+no change group had a slight increase in both PTSD and depression. The TBI+restored sleep group also had significant changes in HRQOL, including the following HRQOL subcomponents: physical functioning, role limitations in physical health, social functioning, emotional well-being, energy/fatigue, and general health perceptions. In a linear regression model using a forced entry method, the dependent variable of change in C-reactive protein (CRP) concentrations was significantly related to changes in PTSD symptoms and HRQOL in the TBI+restored sleep group, with R2=0.43, F33,3=8.31, p<.01.
  
  
  CONCLUSIONS
  Military personnel with TBIs who have a reduction in insomnia symptoms following a standard-of-care treatment report less severe symptoms of depression and PTSD and improved HRQOL, which relate to decreased plasma concentrations of CRP. These findings suggest that treatment for sleep disturbances in this TBI+military population is associated with improvements in health and decreases in inflammation. The contributions of inflammation-induced changes in PTSD and depression in sleep disturbances in TBI + military personnel require further study.
authors.forename: Taura
authors.initials: T
authors.lastname: Barr
authors.forename: Whitney
authors.initials: W
authors.lastname: Livingston
authors.forename: Pedro
authors.initials: P
authors.lastname: Guardado
authors.forename: Tristin
authors.initials: T
authors.lastname: Baxter
authors.forename: Vincent
authors.initials: V
authors.lastname: Mysliwiec
authors.forename: Jessica
authors.initials: J
authors.lastname: Gill
mesh_terms: D000328:Adult; D001930:Brain Injuries / Q000150:complications / Q000276:immunology / Q000523:psychology*; D002097:C-Reactive Protein / Q000276:immunology; D015928:Cognitive Behavioral Therapy; D045422:Continuous Positive Airway Pressure; D003863:Depression / Q000150:complications / Q000276:immunology / Q000523:psychology / Q000628:therapy; D003866:Depressive Disorder / Q000150:complications / Q000276:immunology / Q000523:psychology / Q000628:therapy; D005260:Female; D006304:Health Status; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007249:Inflammation; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D008889:Military Personnel / Q000523:psychology*; D011788:Quality of Life / Q000523:psychology*; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000276:immunology / Q000523:psychology* / Q000628:therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000276:immunology / Q000523:psychology / Q000628:therapy*; D013313:Stress Disorders, Post-Traumatic / Q000150:complications / Q000276:immunology / Q000523:psychology*; D016896:Treatment Outcome
chemical_list: D006993:Hypnotics and Sedatives; D002097:C-Reactive Protein